HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Susan M Carlton Selected Research

6,7-dichloro-1H-indole-2,3-dione 3-oxime

5/2015In vivo activation of the SK channel in the spinal cord reduces the NMDA receptor antagonist dose needed to produce antinociception in an inflammatory pain model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Susan M Carlton Research Topics

Disease

20Pain (Aches)
01/2017 - 06/2002
5Hypersensitivity (Allergy)
12/2017 - 07/2013
5Inflammation (Inflammations)
09/2015 - 02/2001
4Chronic Pain
01/2017 - 04/2009
4Hyperalgesia
11/2013 - 01/2009
1Allergic Contact Dermatitis
01/2018
1Substance-Related Disorders (Drug Abuse)
09/2015
1Opioid-Related Disorders (Opiate Addiction)
09/2015
1Neurogenic Inflammation
08/2014
1Acquired Immunodeficiency Syndrome (AIDS)
06/2014
1Neoplasms (Cancer)
09/2013
1Spinal Injuries (Spinal Injury)
11/2010
1Colorectal Neoplasms (Colorectal Cancer)
03/2010
1Testicular Neoplasms (Testicular Cancer)
03/2010
1Painful Neuropathy
03/2010
1Spinal Cord Injuries (Spinal Cord Injury)
04/2009
1Neuralgia (Stump Neuralgia)
04/2009

Drug/Important Bio-Agent (IBA)

4Freund's AdjuvantIBA
09/2015 - 06/2002
3Opioid Analgesics (Opioids)IBA
09/2015 - 07/2013
3Pharmaceutical PreparationsIBA
11/2013 - 06/2002
3Capsaicin (Zostrix)FDA Link
06/2012 - 07/2004
3GalaninIBA
09/2006 - 07/2004
2Proteins (Proteins, Gene)FDA Link
06/2014 - 06/2012
2Morphine (MS Contin)FDA LinkGeneric
11/2013 - 07/2013
1squaric acidIBA
01/2018
1Ligand-Gated Ion ChannelsIBA
12/2017
1Ion Channels (Ion Channel)IBA
12/2017
1ezogabine (retigabine)IBA
01/2017
1Glutamic Acid (Glutamate)FDA Link
11/2015
1Opioid Receptors (Opioid Receptor)IBA
09/2015
1Heroin (Diamorphine)IBA
09/2015
1mu Opioid Receptors (mu Opioid Receptor)IBA
09/2015
1Dopamine (Intropin)FDA LinkGeneric
09/2015
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
05/2015
16,7-dichloro-1H-indole-2,3-dione 3-oximeIBA
05/2015
1Neurotransmitter Agents (Neurotransmitter)IBA
08/2014
1Transient Receptor Potential ChannelsIBA
12/2013
1Irritants (Vesicants)IBA
09/2013
1RetinoidsIBA
09/2013
1CateninsIBA
06/2012
1AutoreceptorsIBA
09/2011
1Formaldehyde (Formol)FDA Link
09/2011
1Carisoprodol (Soma)FDA LinkGeneric
11/2010
1salicylhydroxamic acid (SHAM)IBA
11/2010
1Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2010
1Cisplatin (Platino)FDA LinkGeneric
03/2010
1Reactive Oxygen Species (Oxygen Radicals)IBA
04/2009
1ColforsinIBA
01/2009
1Galanin Receptors (Galanin Receptor)IBA
09/2006
1Protein Kinase CIBA
09/2005
1NeuropeptidesIBA
09/2005
1calphostin CIBA
09/2005
1Somatostatin Receptors (Somatostatin Receptor)IBA
08/2004
1Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
06/2002
1Substance PIBA
06/2002
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
06/2002
1Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
02/2001

Therapy/Procedure

2Pain Management
09/2015 - 12/2013
1Self Administration (Administration, Self)
09/2015
1Spinal Injections
06/2014
1Ligation
06/2012
1Therapeutics
01/2009